Metoclopramide and cellular immune functions during polymicrobial sepsis.
Metoclopramide (MCP) has been demonstrated to restore the depressed cellular immune function after hemorrhage by increasing the release of the immunomodulatory pituitary hormone prolactin. We investigated the effect of MCP on serum prolactin concentrations, on cellular immune functions (immune cell distribution, splenocyte proliferation, apoptosis and cytokine release) and on the survival 48 h after induction of a polymicrobial sepsis in mice. Administration of MCP increased circulating serum prolactin concentrations and splenocyte apoptosis rate and improved cellular cytokine release, but did not affect mortality of septic mice. We therefore conclude that administration of MCP modulated splenocyte apoptosis and cytokine release in a murine model of sepsis without an impact on the survival. Furthermore, this effect may be mediated by an increased endogenous prolactin release.
Department of Trauma Surgery, University Hospital of Essen, Essen, Germany. reineroberbeck@hotmail.com
R
R
Oberbeck
D
D
Schmitz
K
K
Wilsenack
M
M
Schüler
B
B
Pehle
M
M
Schedlowski
M S
MS
Exton
D000818:Animals; D017209:Apoptosis / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology; D018492:Dopamine Antagonists / Q000276:immunology / Q000494:pharmacology*; D007111:Immunity, Cellular / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008787:Metoclopramide / Q000276:immunology / Q000494:pharmacology*; D051379:Mice; D023421:Models, Animal; D011388:Prolactin / Q000097:blood; D018805:Sepsis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D016019:Survival Analysis; D018746:Systemic Inflammatory Response Syndrome / Q000276:immunology
D016207:Cytokines; D018492:Dopamine Antagonists; D011388:Prolactin; D008787:Metoclopramide